Danaher Corp.
DHR · NYSE · Healthcare
229.03USD−2.47▼ −1.07%
Prices delayed 15 minutes
Key data
- Market cap
- 161B USD
- P/E ratio
- 45.35
- EPS (trailing 12 months)
- 5.05 USD
- Revenue (trailing 12 months)
- 24.57B USD
- Dividend yield
- 0.66%
- Price-to-book
- 3.06
- Beta (volatility)
- 0.41
- Average volume (20 sessions)
- 4.23M
52-week low and high
160.93242.80
Latest news & analysis
Company filingsDanaher Appoints Two New Board Members and Announces Retirement of AnotherDanaher announced the appointment of Daniel Comas and Robert Hirschberg to its board of directors effective immediately, while Alan Spoon informed the board of his decision to retire effective at the 2027 annual shareholders meeting.Company filingsDanaher: Changes in Executive Management or Board of Directors and Other EventsDanaher (DHR) disclosed to the US Securities and Exchange Commission (SEC): changes in executive management or board of directors, other events.
For information only; not a recommendation to buy or sell. Prices may be delayed up to 15 minutes.